+
Site Tour

EuroEcho 2021: Advances to optimize tricuspid regurgitation management: the evidence

Maurizio Taramasso presents on the clinical and real-world outcomes from the TRILUMINATE trial and TriClip™ bRIGHT study, respectively.

Related Videos

SAFETY IS A JOURNEY | X. Freixa & F. Castriota

EuroEcho 2021: MR Treatment (Evidence)

EACVI Summit 2023: Congress symposium

TriClip™: Clinical evidence

EuroPCR 2023: Defining the future

Navitor™: Voice of the Experts Federico de Marco

M-TEER: echo procedural approach

Anatomical overview of the AV Valves

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

EXPAND Study: Data overview

ESC 2021: HF & VHD Guidelines

PCRLV 2021: Transcatheter mitral valve replacement

Tendyne™: 6-Year Outcomes

CONNEXT


LIVE
RELATED EVENTS

TAVI Summit - Cardiac imaging and morphology

AV VALVES 2023: The Genesis of TEER

Now you've got Navitor. Remarkable performance.

Now you've got Navitor.
Future ready.

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline